Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Tech Cabo Verde.
Press releases published on July 14, 2025
Disc Medicine Appoints Nadim Ahmed to its Board of Directors
GlobeNewswire
·
July 14, 2025
WATERTOWN, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …
Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard
GlobeNewswire
·
July 14, 2025
HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on July 10, 2025 the Company received notification from The Nasdaq Stock Market LLC (Nasdaq) of an additional extension to …
Unlock the Next Bitcoin‑Scale Boom with ABQuant’s BTCQuant Platform
GlobeNewswire
·
July 14, 2025
Washington, D.C, July 14, 2025 (GLOBE NEWSWIRE) -- As Bitcoin surged over 300% between 2020 and 2023, digital assets have moved from speculative bets to a central pillar of modern finance. Billionaires like Elon Musk and Michael Saylor, and institutions …
Full Alliance Group Launches Qubitera Holdings, to Develop Quant Blockchain and YAHBEE Wallet for Healthcare and Web3
GlobeNewswire
·
July 14, 2025
TAMPA, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group Inc. (OTC: FAGI) today announced the formation of Qubitera Holdings, Inc., a majority-owned subsidiary (80% ownership), created to lead the development of decentralized infrastructure and …
Endless Developer Grant Program Concludes First Stage, Crowns StarAI, Funmeta, and VDEP as Tier 1 Winners
GlobeNewswire
·
July 14, 2025
London, UK, July 14, 2025 (GLOBE NEWSWIRE) -- At the Brunel Hack 25 - Blockchain Hackathon …
Real World Data Supports Results of Route 92 Medical’s SUMMIT MAX Clinical Trial
GlobeNewswire
·
July 14, 2025
SAN MATEO, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced results from an independent, real- …
Recludix Pharma Announces Strengthening of Leadership Team, Including Promotion of Dr. Brian Hodous to Chief Scientific Officer
GlobeNewswire
·
July 14, 2025
--Brian Hodous, Ph.D., promoted to chief scientific officer -- Vivek Kadambi, Ph.D., joins Recludix as senior vice president of non-clinical sciences and CMC -- Kristin Polsenski, M.B.A., expands role to include chief of staff to the CEO SAN DIEGO, July 14 …
MKS Inc. Announces Second Quarter 2025 Earnings Conference Call
GlobeNewswire
·
July 14, 2025
ANDOVER, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release second quarter 2025 financial results after market close on …
INSPIRED Launches New Social Media Platform that Brings Together Innovators, Investors and Collaborators to Fuel Purpose-Driven Ideas
GlobeNewswire
·
July 14, 2025
ZÜRICH, Switzerland, July 14, 2025 (GLOBE NEWSWIRE) -- INSPIRED today announces the launch of its new social media platform where innovators, investors and collaborators can connect to turn world-changing ideas into reality. By empowering purpose-driven …
JenaValve Announces First Patient Enrolled in ARTIST Randomized Controlled Trial (RCT) Evaluating the Trilogy™ System in Aortic Regurgitation (AR)
GlobeNewswire
·
July 14, 2025
IRVINE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that patient enrollment has begun in the ARTIST study, an RCT evaluating the …
LyondellBasell improves CDP climate score to A in 2024, strengthening ESG leadership
GlobeNewswire
·
July 14, 2025
HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB) today announced it has improved its climate change score from A-minus to A in CDP’s 2024 assessment, placing the company in the leadership category for the second consecutive year. CDP …
Applied Digital Sets Fiscal Fourth Quarter and Full Year 2025 Conference Call for Wednesday, July 30, 2025, at 5:00 p.m. Eastern Time
GlobeNewswire
·
July 14, 2025
DALLAS, July 14, 2025 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of next-generation digital infrastructure designed for High-Performance Computing (HPC) …
Health Canada Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)
GlobeNewswire
·
July 14, 2025
TORONTO, July 14, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialisation of novel therapies for rare and ultra-rare genetic diseases, today announced that Health …
Santé Canada étend l’approbation d’Evkeeza® (évinacumab) chez les enfants âgés d’à peine 6 mois atteints d’hypercholestérolémie familiale homozygote (HFHo)
GlobeNewswire
·
July 14, 2025
TORONTO, 14 juill. 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ : RARE), une société biopharmaceutique spécialisée dans la mise au point et la commercialisation de nouveaux traitements contre des maladies génétiques rares et très rares, …
Rumble Names Ian O’Donnell VP for Rumble Cloud
GlobeNewswire
·
July 14, 2025
LONGBOAT KEY, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- Rumble (NASDAQ:RUM), the video-sharing platform and cloud services provider, today announced the hiring of Ian O’Donnell, a 20-year veteran of technology sales and marketing, as the company’s Vice …
Study: First Brain Fitness Tracker Validated for Aging Independently
GlobeNewswire
·
July 14, 2025
SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- A new study shows that a novel online assessment (here) provides a valid scientific measure of the cognitive abilities of older adults related to living independently. The self-administered assessment can be …
Gero Appoints Longevity Expert Dr. Brian Kennedy to Board of Directors
GlobeNewswire
·
July 14, 2025
SINGAPORE, July 14, 2025 (GLOBE NEWSWIRE) -- Gero, an AI-driven biotechnology company focused on developing therapeutics for age-related diseases, today announced the appointment of Brian Kennedy, Ph.D., to its Board of Directors. Dr. Kennedy is a globally …
Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive
GlobeNewswire
·
July 14, 2025
SAN DIEGO, July 14, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority, today announced positive interim safety and efficacy results …
Phunware Announces Updates to Senior Leadership Team
GlobeNewswire
·
July 14, 2025
Jeremy Krol Appointed as Interim Chief Executive Officer and Rahul Mewawalla Appointed as Executive Chairman and Chief AI Architect AUSTIN, Texas, July 14, 2025 (GLOBE NEWSWIRE) -- Phunware, Inc. (NASDAQ: PHUN) (“Phunware” or the “Company”), today …
ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat
GlobeNewswire
·
July 14, 2025
New “Decision to grant” communications in Canada and Israel For the treatment of aggression and social withdrawal MADRID and CAMBRIDGE, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage …